Lessons from EVA-3S and SPACE
Authors:
- 23 October 2007
- journal article
- review article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 31 (1) , 5-7
Abstract
Carotid endarterectomy (CEA) was established as the gold standard for treatment of carotid occlusive disease by several landmark papers published in the 1990s. With the continued trend toward less invasive therapies, carotid artery stenting (CAS) has challenged CEA for treatment of significant carotid artery disease. Several trials have now compared CEA and CAS and a subsequent Cochrane review indicated that the 30-day complication rates were equivalent. Unfortunately, comparative long-term data are still lacking. Two new trials comparing CAS with CAE in patients with symptomatic internal carotid artery disease have recently been published, but to what extent have they usefully added to the available data?Keywords
This publication has 6 references indexed in Scilit:
- Appropriateness of learning curve for carotid artery stenting: An analysis of periprocedural complicationsJournal of Vascular Surgery, 2006
- Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid StenosisNew England Journal of Medicine, 2006
- 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trialThe Lancet, 2006
- Complications and Follow-up after Unprotected Carotid Artery StentingCardioVascular and Interventional Radiology, 2006
- Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary InterventionJACC, 2005
- The Benefits of Combined Anti-platelet Treatment in Carotid Artery StentingEuropean Journal of Vascular and Endovascular Surgery, 2005